January 29, 2024 | New York Law Journal
Major Milestone for Psychedelic-Assisted Therapy: Lykos Therapeutics Submits New Drug Application to the FDA for MDMA-Assisted Therapy for PTSDOn Dec. 12, 2023, MAPS PBC, now Lykos Therapeutics, announced their submission of a New Drug Application to the FDA for MDMA in combination with psychotherapy for the treatment of post-traumatic stress disorder.
By Lisa L. Smith, Eric M. Kraus and Julia M. Markov
7 minute read
Trending Stories